Study on How Insulin Analogues Affect Tumor Growth in Endometrial and Colon Cancer

Sponsor: Meir Medical Center

Expanded Access
Sponsor score: 60
Inactive

ClinicalTrials ID:NCT01267461

Provider View

This study is exploring whether certain long-acting insulin analogues might influence the growth of cancer cells in patients with endometrial and colon cancer. Researchers aim to understand how these insulin analogues interact with cancer cells and their potential impact on tumor behavior.

Patient Parameters

Program Overview

The purpose of this study is to investigate if long-acting insulin analogues, which are used to manage blood sugar levels, could affect the growth and behavior of cancer cells in endometrial and colon cancer. Researchers are examining how these insulin analogues might promote cell growth and prevent cell death in cancer cells, which could potentially influence how tumors develop and respond to treatment.

Eligibility Criteria

Inclusion Criteria

  • Patients diagnosed with endometrial cancer.
  • Patients diagnosed with colon cancer.

Exclusion Criteria

  • None

Get This Program In Your Inbox

Receive detailed information about this treatment opportunity to review with your healthcare provider.